ATMP Sweden is a national network for activities within medicines based on genes, cells or tissue engineering, classified as Advanced Therapy Medicinal Products (ATMPs) in Europe. Our goal is to promote the collaboration and communication that is needed for accelerated and effective ATMP based patient solutions.
We provide centralizing, coordination and communication functions to Swedish ATMP stakeholders towards making Sweden world leading in ATMP by 2030. We are open to all Swedish ATMP stakeholders and aim to be an internationally leading center in facilitating the implementation of ATMPs.
We also act as a central contact point both nationally and internationally for the Swedish ATMP field.
Founded by initiatives and projects
The ATMP Sweden network was founded through the Vinnova funded projects CAMP (Centre for Advanced Medical Products) and Swelife-ATMP. The activity is now supported by the Vinnova funded ATMP Innovation Milieu.
Other Swedish ATMP specific National networks within the ATMP Sweden umbrella include NextGenNK focused on cost effective development of Natural Killer (NK) cell based therapies and SWECARNET, Sweden’s network for clinical use of CAR T cells.
Promote human health through innovations
Our purpose is to promote human health through breakthrough innovations in academia, healthcare and industry. We do this by building networks and projects within;
- research and innovation
- documentation support
- clinical trials
- commercialization and reimbursement
- training and competence development.
Activities and communication
ATMP Sweden runs the annual Swedish conference ATMP Sweden and the ATMP World Tour. We also maintain the atmpsweden.se website, the ATMP Sweden Linkedin page and the ATMP Sweden newsletter – a quarterly newsletter updating on Swedish ATMP developments.